Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.72647294 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.61922576 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.60774541 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.60774541 |
5 | histone H3-K36 demethylation (GO:0070544) | 4.09852227 |
6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.89586335 |
7 | mannose metabolic process (GO:0006013) | 3.80744928 |
8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.71595574 |
9 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.57184339 |
10 | interkinetic nuclear migration (GO:0022027) | 3.55988742 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.50658467 |
12 | histone H3-K9 modification (GO:0061647) | 3.44599797 |
13 | cellular response to ethanol (GO:0071361) | 3.39794586 |
14 | positive regulation of granulocyte differentiation (GO:0030854) | 3.21761376 |
15 | positive regulation of developmental pigmentation (GO:0048087) | 3.20808854 |
16 | histone H3-K9 methylation (GO:0051567) | 3.19335349 |
17 | striated muscle atrophy (GO:0014891) | 3.17889063 |
18 | regulation of histone H3-K27 methylation (GO:0061085) | 3.16890410 |
19 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.16814043 |
20 | surfactant homeostasis (GO:0043129) | 3.14990419 |
21 | nuclear pore complex assembly (GO:0051292) | 3.14414093 |
22 | histone H3-K4 trimethylation (GO:0080182) | 3.12434699 |
23 | positive thymic T cell selection (GO:0045059) | 3.10206954 |
24 | cellular response to zinc ion (GO:0071294) | 3.05116011 |
25 | regulation of B cell differentiation (GO:0045577) | 3.02960995 |
26 | pericardium development (GO:0060039) | 3.02769600 |
27 | positive regulation of B cell differentiation (GO:0045579) | 3.01301682 |
28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.97972611 |
29 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.94354181 |
30 | regulation of RNA export from nucleus (GO:0046831) | 2.93646437 |
31 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.93562443 |
32 | embryonic process involved in female pregnancy (GO:0060136) | 2.83182821 |
33 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.81594269 |
34 | positive regulation of interferon-alpha production (GO:0032727) | 2.80261898 |
35 | skeletal muscle adaptation (GO:0043501) | 2.79766691 |
36 | neutrophil activation involved in immune response (GO:0002283) | 2.79711966 |
37 | negative regulation of histone methylation (GO:0031061) | 2.78508516 |
38 | negative regulation of myotube differentiation (GO:0010832) | 2.77941336 |
39 | B cell receptor signaling pathway (GO:0050853) | 2.76862762 |
40 | nuclear pore organization (GO:0006999) | 2.74811401 |
41 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.73681942 |
42 | histone lysine methylation (GO:0034968) | 2.72512435 |
43 | peptidyl-lysine dimethylation (GO:0018027) | 2.71490357 |
44 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.71483539 |
45 | hepatocyte apoptotic process (GO:0097284) | 2.70000490 |
46 | immunoglobulin mediated immune response (GO:0016064) | 2.68611602 |
47 | negative regulation of fatty acid transport (GO:2000192) | 2.68174925 |
48 | chemical homeostasis within a tissue (GO:0048875) | 2.68003932 |
49 | peptidyl-lysine methylation (GO:0018022) | 2.67305072 |
50 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.66489590 |
51 | response to muramyl dipeptide (GO:0032495) | 2.66423843 |
52 | iron ion import (GO:0097286) | 2.65954037 |
53 | corticosteroid receptor signaling pathway (GO:0031958) | 2.65279141 |
54 | lipid translocation (GO:0034204) | 2.63542252 |
55 | phospholipid translocation (GO:0045332) | 2.63542252 |
56 | NIK/NF-kappaB signaling (GO:0038061) | 2.63383130 |
57 | regulation of interferon-alpha production (GO:0032647) | 2.63063071 |
58 | protein K48-linked deubiquitination (GO:0071108) | 2.62734931 |
59 | pre-miRNA processing (GO:0031054) | 2.60903060 |
60 | cellular response to exogenous dsRNA (GO:0071360) | 2.57463173 |
61 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.52429833 |
62 | negative regulation of cell killing (GO:0031342) | 2.52429833 |
63 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.52347991 |
64 | muscle atrophy (GO:0014889) | 2.51495169 |
65 | positive regulation of protein deacetylation (GO:0090312) | 2.50176001 |
66 | histone H3-K4 methylation (GO:0051568) | 2.49842902 |
67 | negative thymic T cell selection (GO:0045060) | 2.49781993 |
68 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.47577071 |
69 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.46849959 |
70 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.46741866 |
71 | natural killer cell mediated immunity (GO:0002228) | 2.46741866 |
72 | negative T cell selection (GO:0043383) | 2.46082199 |
73 | growth hormone receptor signaling pathway (GO:0060396) | 2.45361685 |
74 | neutrophil activation (GO:0042119) | 2.45258906 |
75 | negative regulation of complement activation (GO:0045916) | 2.44608174 |
76 | regulation of pigment cell differentiation (GO:0050932) | 2.44225702 |
77 | modulation by symbiont of host immune response (GO:0052553) | 2.44058421 |
78 | positive regulation by symbiont of host defense response (GO:0052509) | 2.44058421 |
79 | modulation by symbiont of host defense response (GO:0052031) | 2.44058421 |
80 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44058421 |
81 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.44058421 |
82 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.44058421 |
83 | granulocyte activation (GO:0036230) | 2.42453564 |
84 | thymic T cell selection (GO:0045061) | 2.40599019 |
85 | B cell homeostasis (GO:0001782) | 2.39186738 |
86 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.39172424 |
87 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.38779013 |
88 | myeloid dendritic cell activation (GO:0001773) | 2.38712625 |
89 | peptidyl-lysine trimethylation (GO:0018023) | 2.38432405 |
90 | cell-substrate adherens junction assembly (GO:0007045) | 2.38018594 |
91 | focal adhesion assembly (GO:0048041) | 2.38018594 |
92 | positive regulation of histone deacetylation (GO:0031065) | 2.37574871 |
93 | pinocytosis (GO:0006907) | 2.37273085 |
94 | definitive hemopoiesis (GO:0060216) | 2.36833300 |
95 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.36778113 |
96 | germinal center formation (GO:0002467) | 2.35698354 |
97 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 2.34070218 |
98 | T cell migration (GO:0072678) | 2.33467134 |
99 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.32340015 |
100 | regulation of establishment of cell polarity (GO:2000114) | 2.32068617 |
101 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.31878514 |
102 | negative regulation of protein activation cascade (GO:2000258) | 2.30021281 |
103 | negative regulation of humoral immune response (GO:0002921) | 2.29836722 |
104 | histone lysine demethylation (GO:0070076) | 2.29178573 |
105 | positive regulation of isotype switching (GO:0045830) | 2.28192128 |
106 | regulation of granulocyte differentiation (GO:0030852) | 2.25904948 |
107 | positive regulation of antigen processing and presentation (GO:0002579) | 2.25882269 |
108 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.25615137 |
109 | positive regulation of humoral immune response (GO:0002922) | 2.25055025 |
110 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.24625587 |
111 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.24255629 |
112 | morphogenesis of an endothelium (GO:0003159) | 2.23256935 |
113 | endothelial tube morphogenesis (GO:0061154) | 2.23256935 |
114 | natural killer cell differentiation (GO:0001779) | 2.22574615 |
115 | mitochondrion distribution (GO:0048311) | 2.22547357 |
116 | N-terminal protein amino acid acetylation (GO:0006474) | 2.22537806 |
117 | regulation of cholesterol storage (GO:0010885) | 2.21201188 |
118 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.21078254 |
119 | response to type I interferon (GO:0034340) | 2.20703705 |
120 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.20094431 |
121 | myeloid dendritic cell differentiation (GO:0043011) | 2.19521740 |
122 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.19255438 |
123 | B cell mediated immunity (GO:0019724) | 2.18369513 |
124 | determination of adult lifespan (GO:0008340) | 2.18350431 |
125 | pore complex assembly (GO:0046931) | 2.17503250 |
126 | myofibril assembly (GO:0030239) | 2.16404983 |
127 | macrophage activation involved in immune response (GO:0002281) | 2.16336663 |
128 | T cell lineage commitment (GO:0002360) | 2.16256234 |
129 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.15958211 |
130 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.15958211 |
131 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.15958211 |
132 | response to peptidoglycan (GO:0032494) | 2.15833506 |
133 | phosphatidylinositol phosphorylation (GO:0046854) | 2.15675905 |
134 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.15589788 |
135 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.14015289 |
136 | histone demethylation (GO:0016577) | 2.14003628 |
137 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.12794041 |
138 | low-density lipoprotein particle clearance (GO:0034383) | 2.12413233 |
139 | histone methylation (GO:0016571) | 2.12369949 |
140 | fibroblast migration (GO:0010761) | 2.12194998 |
141 | type I interferon signaling pathway (GO:0060337) | 2.11932293 |
142 | cellular response to type I interferon (GO:0071357) | 2.11932293 |
143 | respiratory burst (GO:0045730) | 2.11830168 |
144 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.11643577 |
145 | positive regulation of interferon-beta production (GO:0032728) | 2.11047246 |
146 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.10889622 |
147 | snRNA transcription (GO:0009301) | 2.10889086 |
148 | I-kappaB phosphorylation (GO:0007252) | 2.10368877 |
149 | regulation of T cell tolerance induction (GO:0002664) | 2.09549137 |
150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.09030301 |
151 | regulation of necroptotic process (GO:0060544) | 2.08733434 |
152 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.08708791 |
153 | leukocyte cell-cell adhesion (GO:0007159) | 2.07719696 |
154 | myeloid cell homeostasis (GO:0002262) | 2.07397432 |
155 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.06599521 |
156 | JAK-STAT cascade (GO:0007259) | 2.06568756 |
157 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.06160945 |
158 | cellular extravasation (GO:0045123) | 2.05990166 |
159 | positive regulation of interleukin-2 production (GO:0032743) | 2.05975371 |
160 | T cell selection (GO:0045058) | 2.05588742 |
161 | cellular response to growth hormone stimulus (GO:0071378) | 2.04586793 |
162 | regulation of hypersensitivity (GO:0002883) | 2.04069713 |
163 | T cell apoptotic process (GO:0070231) | 2.03568153 |
164 | leukocyte aggregation (GO:0070486) | 2.03500050 |
165 | COPI coating of Golgi vesicle (GO:0048205) | 2.03191564 |
166 | Golgi transport vesicle coating (GO:0048200) | 2.03191564 |
167 | response to laminar fluid shear stress (GO:0034616) | 2.02593297 |
168 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.01035544 |
169 | positive regulation of interleukin-12 production (GO:0032735) | 2.00791472 |
170 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.00636868 |
171 | regulation of response to interferon-gamma (GO:0060330) | 2.00246870 |
172 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.00102801 |
173 | valine metabolic process (GO:0006573) | 1.99300452 |
174 | positive regulation of p38MAPK cascade (GO:1900745) | 1.99250804 |
175 | positive regulation of lipid storage (GO:0010884) | 1.98330673 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.57794014 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.67660198 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.26384342 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.05247986 |
5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.03789650 |
6 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 3.00534769 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.97725724 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.96769728 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.70337345 |
10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.54379221 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37240490 |
12 | MYC_22102868_ChIP-Seq_BL_Human | 2.36675364 |
13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34899159 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.34005543 |
15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33243965 |
16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30528780 |
17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.22520341 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.17298265 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.16169930 |
20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.15732803 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08678801 |
22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.07793090 |
23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05556416 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04554454 |
25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.03746496 |
26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.01996911 |
27 | MAF_26560356_Chip-Seq_TH1_Human | 1.97377956 |
28 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.97136299 |
29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.95903118 |
30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.92282838 |
31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89763252 |
32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.85457399 |
33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84694535 |
34 | MYB_26560356_Chip-Seq_TH2_Human | 1.83926475 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83579088 |
36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.78770857 |
37 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75877887 |
38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.75552884 |
39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74381581 |
40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72196042 |
41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70454000 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.70406491 |
43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.69901668 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68891432 |
45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64415127 |
46 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63885731 |
47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.63413527 |
48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.62628568 |
49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62366332 |
50 | MYB_26560356_Chip-Seq_TH1_Human | 1.62170001 |
51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.61577091 |
52 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.61491698 |
53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59990963 |
54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59423291 |
55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58603325 |
56 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58553946 |
57 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.56077737 |
58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.54610516 |
59 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.52387397 |
60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51230908 |
61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49691541 |
62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45659364 |
63 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.44284334 |
64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43805906 |
65 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42434875 |
66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42432440 |
67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42132783 |
68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41546431 |
69 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41419348 |
70 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.39114196 |
71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38656665 |
72 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.38586436 |
73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34126777 |
74 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31622413 |
75 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31424249 |
76 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31335515 |
77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31300528 |
78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30146432 |
79 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.26234109 |
80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25422924 |
81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24876280 |
82 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.24559058 |
83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24192838 |
84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24160808 |
85 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.21047574 |
86 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.20930403 |
87 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.20930403 |
88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20424785 |
89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20029793 |
90 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19651357 |
91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18363105 |
92 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.17826104 |
93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15891116 |
94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15571878 |
95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14618397 |
96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13809559 |
97 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12996401 |
98 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12519632 |
99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11843310 |
100 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11421318 |
101 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11256168 |
102 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11041136 |
103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10938560 |
104 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.10694691 |
105 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.10271995 |
106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09872884 |
107 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07956140 |
108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07827011 |
109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07714608 |
110 | * MAF_26560356_Chip-Seq_TH2_Human | 1.07253611 |
111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06839625 |
112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04927424 |
113 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03297533 |
114 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02966902 |
115 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02526313 |
116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02432996 |
117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02212995 |
118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01426532 |
119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01388377 |
120 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01067014 |
121 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01067014 |
122 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00376091 |
123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.00307248 |
124 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.99423538 |
125 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.98565507 |
126 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97218929 |
127 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96732460 |
128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96422401 |
129 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95215159 |
130 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93842681 |
131 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.93748589 |
132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93651674 |
133 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93614128 |
134 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92906658 |
135 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92801525 |
136 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92268870 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008057_abnormal_DNA_replication | 3.27296074 |
2 | MP0001835_abnormal_antigen_presentation | 2.94557930 |
3 | MP0000685_abnormal_immune_system | 2.35083383 |
4 | MP0003300_gastrointestinal_ulcer | 2.16497162 |
5 | MP0001790_abnormal_immune_system | 2.15508917 |
6 | MP0005387_immune_system_phenotype | 2.15508917 |
7 | MP0003436_decreased_susceptibility_to | 2.12534568 |
8 | MP0001800_abnormal_humoral_immune | 2.02810638 |
9 | MP0005451_abnormal_body_composition | 2.02573935 |
10 | MP0003705_abnormal_hypodermis_morpholog | 1.97945627 |
11 | MP0009785_altered_susceptibility_to | 1.89161009 |
12 | MP0005000_abnormal_immune_tolerance | 1.87381450 |
13 | * MP0002452_abnormal_antigen_presenting | 1.87156637 |
14 | MP0004381_abnormal_hair_follicle | 1.84275979 |
15 | MP0002166_altered_tumor_susceptibility | 1.81206745 |
16 | MP0002138_abnormal_hepatobiliary_system | 1.77408928 |
17 | MP0002148_abnormal_hypersensitivity_rea | 1.77249160 |
18 | MP0003303_peritoneal_inflammation | 1.74186327 |
19 | MP0005025_abnormal_response_to | 1.69244375 |
20 | MP0006054_spinal_hemorrhage | 1.68980679 |
21 | * MP0002419_abnormal_innate_immunity | 1.67725124 |
22 | MP0005671_abnormal_response_to | 1.65776028 |
23 | MP0002723_abnormal_immune_serum | 1.65140799 |
24 | MP0003763_abnormal_thymus_physiology | 1.64070118 |
25 | MP0004782_abnormal_surfactant_physiolog | 1.63596414 |
26 | MP0004947_skin_inflammation | 1.58595576 |
27 | * MP0002420_abnormal_adaptive_immunity | 1.58396379 |
28 | * MP0001819_abnormal_immune_cell | 1.57746761 |
29 | MP0010352_gastrointestinal_tract_polyps | 1.54648769 |
30 | MP0003566_abnormal_cell_adhesion | 1.54580504 |
31 | MP0002254_reproductive_system_inflammat | 1.53980779 |
32 | MP0002006_tumorigenesis | 1.53978188 |
33 | MP0001853_heart_inflammation | 1.52659898 |
34 | MP0008438_abnormal_cutaneous_collagen | 1.50432450 |
35 | MP0002405_respiratory_system_inflammati | 1.49605691 |
36 | MP0004084_abnormal_cardiac_muscle | 1.49528935 |
37 | MP0005310_abnormal_salivary_gland | 1.48663527 |
38 | MP0004510_myositis | 1.47232663 |
39 | MP0010155_abnormal_intestine_physiology | 1.42460067 |
40 | MP0004036_abnormal_muscle_relaxation | 1.38847226 |
41 | MP0006082_CNS_inflammation | 1.36293496 |
42 | MP0001661_extended_life_span | 1.36162078 |
43 | MP0002398_abnormal_bone_marrow | 1.36091757 |
44 | MP0003950_abnormal_plasma_membrane | 1.33212737 |
45 | MP0002877_abnormal_melanocyte_morpholog | 1.32326644 |
46 | MP0001845_abnormal_inflammatory_respons | 1.30746870 |
47 | MP0005076_abnormal_cell_differentiation | 1.28717156 |
48 | * MP0000716_abnormal_immune_system | 1.28692363 |
49 | MP0000371_diluted_coat_color | 1.27715415 |
50 | MP0005409_darkened_coat_color | 1.26438851 |
51 | MP0003890_abnormal_embryonic-extraembry | 1.26377738 |
52 | MP0003453_abnormal_keratinocyte_physiol | 1.24335130 |
53 | MP0004233_abnormal_muscle_weight | 1.24093380 |
54 | MP0000858_altered_metastatic_potential | 1.22965125 |
55 | MP0003828_pulmonary_edema | 1.22444484 |
56 | MP0001873_stomach_inflammation | 1.21094999 |
57 | MP0010234_abnormal_vibrissa_follicle | 1.18578308 |
58 | MP0008961_abnormal_basal_metabolism | 1.18469335 |
59 | MP0009278_abnormal_bone_marrow | 1.17944224 |
60 | MP0005464_abnormal_platelet_physiology | 1.17305922 |
61 | MP0002933_joint_inflammation | 1.16718773 |
62 | MP0002168_other_aberrant_phenotype | 1.16689692 |
63 | MP0003724_increased_susceptibility_to | 1.16606147 |
64 | MP0009333_abnormal_splenocyte_physiolog | 1.15534205 |
65 | MP0000689_abnormal_spleen_morphology | 1.14997925 |
66 | MP0003448_altered_tumor_morphology | 1.12882155 |
67 | MP0001533_abnormal_skeleton_physiology | 1.12383992 |
68 | * MP0002429_abnormal_blood_cell | 1.11042442 |
69 | MP0002722_abnormal_immune_system | 1.10426214 |
70 | MP0003279_aneurysm | 1.10128809 |
71 | MP0004808_abnormal_hematopoietic_stem | 1.06890574 |
72 | MP0001879_abnormal_lymphatic_vessel | 1.06607738 |
73 | MP0006138_congestive_heart_failure | 1.06266782 |
74 | MP0003868_abnormal_feces_composition | 1.06251686 |
75 | MP0010307_abnormal_tumor_latency | 1.05822282 |
76 | MP0000015_abnormal_ear_pigmentation | 1.05817850 |
77 | MP0005023_abnormal_wound_healing | 1.05415456 |
78 | MP0005360_urolithiasis | 1.04502336 |
79 | MP0004185_abnormal_adipocyte_glucose | 1.03678032 |
80 | MP0003191_abnormal_cellular_cholesterol | 1.03073061 |
81 | MP0005058_abnormal_lysosome_morphology | 1.02187690 |
82 | MP0008469_abnormal_protein_level | 1.02011216 |
83 | MP0002060_abnormal_skin_morphology | 1.00991289 |
84 | MP0000767_abnormal_smooth_muscle | 0.99747358 |
85 | MP0005397_hematopoietic_system_phenotyp | 0.98921404 |
86 | MP0001545_abnormal_hematopoietic_system | 0.98921404 |
87 | MP0005171_absent_coat_pigmentation | 0.98379601 |
88 | MP0002396_abnormal_hematopoietic_system | 0.98140555 |
89 | MP0005275_abnormal_skin_tensile | 0.97529040 |
90 | MP0000733_abnormal_muscle_development | 0.97411479 |
91 | MP0009840_abnormal_foam_cell | 0.96187636 |
92 | MP0005085_abnormal_gallbladder_physiolo | 0.95247565 |
93 | MP0009115_abnormal_fat_cell | 0.94201620 |
94 | MP0003984_embryonic_growth_retardation | 0.94070226 |
95 | MP0002086_abnormal_extraembryonic_tissu | 0.93954798 |
96 | MP0010094_abnormal_chromosome_stability | 0.93378958 |
97 | * MP0002998_abnormal_bone_remodeling | 0.92956784 |
98 | MP0003656_abnormal_erythrocyte_physiolo | 0.92718249 |
99 | MP0003252_abnormal_bile_duct | 0.92266053 |
100 | MP0009764_decreased_sensitivity_to | 0.91308428 |
101 | MP0002088_abnormal_embryonic_growth/wei | 0.90462576 |
102 | MP0002139_abnormal_hepatobiliary_system | 0.88814237 |
103 | MP0000703_abnormal_thymus_morphology | 0.87690395 |
104 | MP0002136_abnormal_kidney_physiology | 0.87536273 |
105 | MP0000569_abnormal_digit_pigmentation | 0.86251426 |
106 | MP0009643_abnormal_urine_homeostasis | 0.85303958 |
107 | MP0000609_abnormal_liver_physiology | 0.83717363 |
108 | MP0003091_abnormal_cell_migration | 0.82696157 |
109 | MP0000490_abnormal_crypts_of | 0.82446699 |
110 | MP0000343_altered_response_to | 0.81449765 |
111 | MP0000465_gastrointestinal_hemorrhage | 0.81031724 |
112 | MP0005220_abnormal_exocrine_pancreas | 0.80986662 |
113 | MP0000383_abnormal_hair_follicle | 0.79970211 |
114 | MP0003646_muscle_fatigue | 0.79899188 |
115 | MP0000470_abnormal_stomach_morphology | 0.79810349 |
116 | MP0010630_abnormal_cardiac_muscle | 0.79474679 |
117 | MP0001958_emphysema | 0.79220809 |
118 | MP0005083_abnormal_biliary_tract | 0.79039887 |
119 | MP0001243_abnormal_dermal_layer | 0.78746396 |
120 | MP0009697_abnormal_copulation | 0.78646082 |
121 | MP0002925_abnormal_cardiovascular_devel | 0.78546486 |
122 | MP0005621_abnormal_cell_physiology | 0.78119570 |
123 | MP0004264_abnormal_extraembryonic_tissu | 0.78110992 |
124 | MP0001851_eye_inflammation | 0.77481771 |
125 | MP0003183_abnormal_peptide_metabolism | 0.77387220 |
126 | MP0005380_embryogenesis_phenotype | 0.76517560 |
127 | MP0001672_abnormal_embryogenesis/_devel | 0.76517560 |
128 | MP0000249_abnormal_blood_vessel | 0.76390014 |
129 | MP0005174_abnormal_tail_pigmentation | 0.76142144 |
130 | MP0001216_abnormal_epidermal_layer | 0.75942745 |
131 | MP0002009_preneoplasia | 0.75839677 |
132 | MP0005257_abnormal_intraocular_pressure | 0.73885523 |
133 | MP0004130_abnormal_muscle_cell | 0.71958573 |
134 | MP0005666_abnormal_adipose_tissue | 0.71288387 |
135 | MP0010368_abnormal_lymphatic_system | 0.70269820 |
136 | MP0001666_abnormal_nutrient_absorption | 0.70197340 |
137 | MP0002019_abnormal_tumor_incidence | 0.70137258 |
138 | MP0000598_abnormal_liver_morphology | 0.69975973 |
139 | MP0005390_skeleton_phenotype | 0.69687103 |
140 | MP0010678_abnormal_skin_adnexa | 0.69413138 |
141 | MP0003045_fibrosis | 0.69206333 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 3.79195019 |
2 | Recurrent abscess formation (HP:0002722) | 3.28902974 |
3 | Autoimmune thrombocytopenia (HP:0001973) | 3.23427227 |
4 | Clumsiness (HP:0002312) | 3.23206422 |
5 | Dysmetric saccades (HP:0000641) | 3.22712462 |
6 | Recurrent bacterial skin infections (HP:0005406) | 3.18082621 |
7 | Recurrent viral infections (HP:0004429) | 3.04356250 |
8 | Cellulitis (HP:0100658) | 3.01546404 |
9 | Agammaglobulinemia (HP:0004432) | 2.89973122 |
10 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.83839795 |
11 | Spontaneous hematomas (HP:0007420) | 2.73336248 |
12 | Abnormality of T cell number (HP:0011839) | 2.69750088 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66380443 |
14 | Hematochezia (HP:0002573) | 2.65181441 |
15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.62375333 |
16 | Myocardial infarction (HP:0001658) | 2.61996381 |
17 | T lymphocytopenia (HP:0005403) | 2.61869174 |
18 | Myositis (HP:0100614) | 2.60044682 |
19 | Chronic otitis media (HP:0000389) | 2.58108119 |
20 | Recurrent bronchitis (HP:0002837) | 2.57675315 |
21 | Recurrent fungal infections (HP:0002841) | 2.57584103 |
22 | Colitis (HP:0002583) | 2.45047929 |
23 | Interstitial pulmonary disease (HP:0006530) | 2.41954177 |
24 | Inflammation of the large intestine (HP:0002037) | 2.40622920 |
25 | Pustule (HP:0200039) | 2.40419112 |
26 | Osteolytic defects of the hand bones (HP:0009699) | 2.40264684 |
27 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.40264684 |
28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.38494370 |
29 | Mediastinal lymphadenopathy (HP:0100721) | 2.37955017 |
30 | Abnormality of the thoracic spine (HP:0100711) | 2.37747580 |
31 | Long eyelashes (HP:0000527) | 2.36790773 |
32 | Gastrointestinal stroma tumor (HP:0100723) | 2.36474129 |
33 | Osteomyelitis (HP:0002754) | 2.36302189 |
34 | Increased cerebral lipofuscin (HP:0011813) | 2.34732385 |
35 | Periodontitis (HP:0000704) | 2.33576763 |
36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.33245058 |
37 | Gastrointestinal inflammation (HP:0004386) | 2.32619572 |
38 | Genetic anticipation (HP:0003743) | 2.29471829 |
39 | Nasal polyposis (HP:0100582) | 2.29214311 |
40 | Abnormality of the nasal mucosa (HP:0000433) | 2.27824320 |
41 | Vasculitis (HP:0002633) | 2.25955279 |
42 | Prominent nose (HP:0000448) | 2.24392025 |
43 | Prolonged bleeding time (HP:0003010) | 2.22643723 |
44 | Orchitis (HP:0100796) | 2.21725673 |
45 | Meningitis (HP:0001287) | 2.18141490 |
46 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.17129553 |
47 | Abnormality of the fingertips (HP:0001211) | 2.16534410 |
48 | Right ventricular cardiomyopathy (HP:0011663) | 2.16273429 |
49 | Abnormality of T cells (HP:0002843) | 2.16156269 |
50 | Recurrent skin infections (HP:0001581) | 2.16021666 |
51 | Hypoglycemic coma (HP:0001325) | 2.15192025 |
52 | Verrucae (HP:0200043) | 2.14814604 |
53 | Papilloma (HP:0012740) | 2.14814604 |
54 | Gingivitis (HP:0000230) | 2.14065983 |
55 | Gastrointestinal infarctions (HP:0005244) | 2.13976444 |
56 | Abnormality of macrophages (HP:0004311) | 2.13102264 |
57 | Thoracic kyphosis (HP:0002942) | 2.11223253 |
58 | Emphysema (HP:0002097) | 2.09733747 |
59 | Neonatal hypoglycemia (HP:0001998) | 2.08484993 |
60 | Esophageal varix (HP:0002040) | 2.07879131 |
61 | Arterial thrombosis (HP:0004420) | 2.06123664 |
62 | Thrombocytosis (HP:0001894) | 2.02579716 |
63 | Hyperacusis (HP:0010780) | 1.98589277 |
64 | Sandal gap (HP:0001852) | 1.97725696 |
65 | Acute myeloid leukemia (HP:0004808) | 1.95994133 |
66 | Increased connective tissue (HP:0009025) | 1.93788491 |
67 | Hyperkalemia (HP:0002153) | 1.93771570 |
68 | Broad face (HP:0000283) | 1.93485090 |
69 | Epistaxis (HP:0000421) | 1.91472325 |
70 | Pulmonary infiltrates (HP:0002113) | 1.91224876 |
71 | Aortic aneurysm (HP:0004942) | 1.90235044 |
72 | Skin ulcer (HP:0200042) | 1.89687245 |
73 | Retrobulbar optic neuritis (HP:0100654) | 1.89288560 |
74 | Optic neuritis (HP:0100653) | 1.89288560 |
75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.88063343 |
76 | Ventricular tachycardia (HP:0004756) | 1.87876417 |
77 | Peritonitis (HP:0002586) | 1.87762031 |
78 | Menorrhagia (HP:0000132) | 1.87669035 |
79 | Decreased circulating renin level (HP:0003351) | 1.87258918 |
80 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.86863527 |
81 | Autoimmune hemolytic anemia (HP:0001890) | 1.86830163 |
82 | Vacuolated lymphocytes (HP:0001922) | 1.86268886 |
83 | IgM deficiency (HP:0002850) | 1.86047589 |
84 | Acute lymphatic leukemia (HP:0006721) | 1.84436975 |
85 | Abnormality of T cell physiology (HP:0011840) | 1.84409573 |
86 | Abnormality of the columella (HP:0009929) | 1.84071420 |
87 | Lymphopenia (HP:0001888) | 1.83753950 |
88 | Hepatitis (HP:0012115) | 1.83736889 |
89 | Spondylolisthesis (HP:0003302) | 1.83366044 |
90 | Protruding tongue (HP:0010808) | 1.81974925 |
91 | Short chin (HP:0000331) | 1.81937876 |
92 | Hemorrhage of the eye (HP:0011885) | 1.81404845 |
93 | Urticaria (HP:0001025) | 1.80900594 |
94 | Asymmetric septal hypertrophy (HP:0001670) | 1.80383378 |
95 | Gingival bleeding (HP:0000225) | 1.80263869 |
96 | Granulocytopenia (HP:0001913) | 1.79538038 |
97 | Flat acetabular roof (HP:0003180) | 1.79419319 |
98 | Viral hepatitis (HP:0006562) | 1.77703164 |
99 | Dislocated radial head (HP:0003083) | 1.76755670 |
100 | Exercise-induced myalgia (HP:0003738) | 1.76343442 |
101 | Aortic dissection (HP:0002647) | 1.76333168 |
102 | Capillary hemangiomas (HP:0005306) | 1.75282769 |
103 | Leukocytosis (HP:0001974) | 1.74930900 |
104 | Polycythemia (HP:0001901) | 1.74826504 |
105 | Subacute progressive viral hepatitis (HP:0006572) | 1.74560220 |
106 | Narrow palate (HP:0000189) | 1.73912629 |
107 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.73389348 |
108 | Recurrent cutaneous fungal infections (HP:0011370) | 1.73389348 |
109 | Recurrent lower respiratory tract infections (HP:0002783) | 1.72571691 |
110 | Subaortic stenosis (HP:0001682) | 1.70346754 |
111 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.70346754 |
112 | Chronic diarrhea (HP:0002028) | 1.69784002 |
113 | Rectal prolapse (HP:0002035) | 1.69232649 |
114 | Thick nail (HP:0001805) | 1.68829211 |
115 | Sepsis (HP:0100806) | 1.68770231 |
116 | Increased IgE level (HP:0003212) | 1.68728555 |
117 | Truncal obesity (HP:0001956) | 1.68697863 |
118 | Thin bony cortex (HP:0002753) | 1.68602128 |
119 | Eosinophilia (HP:0001880) | 1.68194376 |
120 | Fair hair (HP:0002286) | 1.67742769 |
121 | Bicuspid aortic valve (HP:0001647) | 1.67012205 |
122 | Cerebral aneurysm (HP:0004944) | 1.66989555 |
123 | Recurrent pneumonia (HP:0006532) | 1.66827099 |
124 | Persistence of primary teeth (HP:0006335) | 1.66355344 |
125 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.66145515 |
126 | Mucosal telangiectasiae (HP:0100579) | 1.65864040 |
127 | Protrusio acetabuli (HP:0003179) | 1.65693387 |
128 | Petechiae (HP:0000967) | 1.65002684 |
129 | Chest pain (HP:0100749) | 1.64604971 |
130 | IgA deficiency (HP:0002720) | 1.64392264 |
131 | Lip pit (HP:0100267) | 1.64288537 |
132 | Onion bulb formation (HP:0003383) | 1.64076580 |
133 | Poikiloderma (HP:0001029) | 1.63960928 |
134 | Type 1 muscle fiber predominance (HP:0003803) | 1.63578170 |
135 | Recurrent sinusitis (HP:0011108) | 1.63488616 |
136 | Aneurysm (HP:0002617) | 1.63227397 |
137 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.63213705 |
138 | Ulnar bowing (HP:0003031) | 1.62886883 |
139 | Mitral stenosis (HP:0001718) | 1.62665194 |
140 | Panhypogammaglobulinemia (HP:0003139) | 1.60694716 |
141 | Restrictive lung disease (HP:0002091) | 1.60664304 |
142 | Heterotopia (HP:0002282) | 1.59035225 |
143 | Abnormal platelet volume (HP:0011876) | 1.58636015 |
144 | Syringomyelia (HP:0003396) | 1.57273561 |
145 | Spinal cord lesions (HP:0100561) | 1.57273561 |
146 | Generalized hypopigmentation of hair (HP:0011358) | 1.56935238 |
147 | Micronodular cirrhosis (HP:0001413) | 1.56934305 |
148 | Vertebral arch anomaly (HP:0008438) | 1.56929446 |
149 | Renovascular hypertension (HP:0100817) | 1.55920129 |
150 | Sparse lateral eyebrow (HP:0005338) | 1.55909905 |
151 | Increased mean platelet volume (HP:0011877) | 1.54485023 |
152 | Abnormality of the intrinsic pathway (HP:0010989) | 1.54213198 |
153 | Submucous cleft hard palate (HP:0000176) | 1.52352988 |
154 | Ureteral obstruction (HP:0006000) | 1.52063548 |
155 | Hyporeflexia of lower limbs (HP:0002600) | 1.51388468 |
156 | Germ cell neoplasia (HP:0100728) | 1.50944254 |
157 | Basal cell carcinoma (HP:0002671) | 1.50772239 |
158 | Abnormality of the radial head (HP:0003995) | 1.49384869 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 2.98062725 |
2 | TRIB3 | 2.92748960 |
3 | MAP3K14 | 2.77709401 |
4 | PRPF4B | 2.59574232 |
5 | MAP3K10 | 2.47673734 |
6 | ERN1 | 2.44781211 |
7 | PKN2 | 2.25684762 |
8 | ICK | 2.23715646 |
9 | TTN | 2.17324474 |
10 | JAK3 | 2.13638841 |
11 | TBK1 | 2.05417401 |
12 | TYK2 | 2.04882075 |
13 | STK10 | 1.80280423 |
14 | LRRK2 | 1.78503894 |
15 | FGFR4 | 1.71453972 |
16 | NEK9 | 1.68958183 |
17 | MAP2K3 | 1.61432872 |
18 | SIK1 | 1.57020708 |
19 | CAMK1D | 1.57005735 |
20 | IKBKB | 1.56805172 |
21 | IRAK3 | 1.53458907 |
22 | JAK1 | 1.52333085 |
23 | TGFBR2 | 1.52026730 |
24 | CDC42BPA | 1.51439061 |
25 | AKT3 | 1.50294696 |
26 | EPHA3 | 1.50219864 |
27 | PTK6 | 1.49680357 |
28 | FLT3 | 1.44421981 |
29 | NME2 | 1.44153661 |
30 | IKBKE | 1.42383430 |
31 | CHUK | 1.40990877 |
32 | BLK | 1.40814329 |
33 | FGFR3 | 1.40261157 |
34 | SMG1 | 1.35974918 |
35 | EEF2K | 1.35879731 |
36 | BTK | 1.34083547 |
37 | RPS6KA4 | 1.31209833 |
38 | ZAP70 | 1.31007535 |
39 | BRD4 | 1.29951667 |
40 | CSK | 1.25435494 |
41 | EPHB1 | 1.25310634 |
42 | KIT | 1.23978087 |
43 | TAOK3 | 1.22624149 |
44 | STK4 | 1.19457442 |
45 | IRAK4 | 1.19101314 |
46 | ITK | 1.14366197 |
47 | MAP3K13 | 1.14040474 |
48 | MST4 | 1.13829164 |
49 | CSF1R | 1.13734132 |
50 | NLK | 1.13633917 |
51 | MAP3K3 | 1.11632694 |
52 | MST1R | 1.09790077 |
53 | PIM1 | 1.05334175 |
54 | CAMK1G | 1.02332579 |
55 | STK3 | 0.97793135 |
56 | ACVR1B | 0.96789686 |
57 | TRPM7 | 0.94609884 |
58 | MARK3 | 0.93147195 |
59 | PDPK1 | 0.93095845 |
60 | TEC | 0.92233186 |
61 | TXK | 0.92175741 |
62 | LATS1 | 0.91052910 |
63 | STK24 | 0.89939382 |
64 | TNK2 | 0.89237489 |
65 | PDGFRA | 0.88413385 |
66 | MARK2 | 0.88334130 |
67 | SGK2 | 0.86646286 |
68 | SYK | 0.85668855 |
69 | GRK6 | 0.84711022 |
70 | WNK1 | 0.83670252 |
71 | PIK3CG | 0.82820231 |
72 | PDK1 | 0.82116672 |
73 | DMPK | 0.81373587 |
74 | JAK2 | 0.81247125 |
75 | SGK3 | 0.81099028 |
76 | INSRR | 0.77504492 |
77 | PBK | 0.76247577 |
78 | PRKD2 | 0.74991220 |
79 | RIPK1 | 0.74900199 |
80 | MAPKAPK3 | 0.74585557 |
81 | MAPK12 | 0.74495719 |
82 | LCK | 0.74028380 |
83 | KDR | 0.72323399 |
84 | NUAK1 | 0.72121348 |
85 | BMX | 0.71345412 |
86 | TGFBR1 | 0.71230339 |
87 | HCK | 0.70768129 |
88 | CDK6 | 0.70684498 |
89 | RET | 0.69711362 |
90 | CLK1 | 0.69676078 |
91 | CDK4 | 0.68329575 |
92 | MAP3K7 | 0.67783428 |
93 | FRK | 0.67747134 |
94 | CDK12 | 0.66694584 |
95 | SCYL2 | 0.66023539 |
96 | LYN | 0.64384802 |
97 | MAP3K8 | 0.62657126 |
98 | CDK9 | 0.62286917 |
99 | PRKCQ | 0.61702518 |
100 | RIPK4 | 0.61525695 |
101 | PDGFRB | 0.61448953 |
102 | MAPK7 | 0.60470656 |
103 | HIPK2 | 0.60046441 |
104 | MAP2K2 | 0.59581125 |
105 | RPS6KA6 | 0.59248708 |
106 | DYRK1B | 0.59068856 |
107 | CDK8 | 0.56817174 |
108 | STK38 | 0.56507707 |
109 | ILK | 0.56182088 |
110 | RPS6KA2 | 0.56049849 |
111 | STK38L | 0.54421933 |
112 | MELK | 0.52876975 |
113 | FES | 0.52702673 |
114 | RPS6KB2 | 0.50841980 |
115 | PRKAA1 | 0.50493821 |
116 | RPS6KL1 | 0.49730817 |
117 | RPS6KC1 | 0.49730817 |
118 | OBSCN | 0.49614649 |
119 | MAP3K1 | 0.49327529 |
120 | BCKDK | 0.49148841 |
121 | BMPR1B | 0.48407864 |
122 | MAPKAPK2 | 0.48179923 |
123 | YES1 | 0.47786473 |
124 | SIK2 | 0.47450893 |
125 | PASK | 0.46546735 |
126 | TLK1 | 0.45428858 |
127 | TIE1 | 0.45298218 |
128 | PIM2 | 0.45166525 |
129 | KSR2 | 0.43095097 |
130 | ABL1 | 0.42289855 |
131 | IRAK1 | 0.41795105 |
132 | PRKAA2 | 0.39997761 |
133 | MAPK11 | 0.38944362 |
134 | NEK2 | 0.38602047 |
135 | MTOR | 0.38246117 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55008417 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41364687 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.33433872 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15188937 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.88823847 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85093364 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81915550 |
8 | Legionellosis_Homo sapiens_hsa05134 | 1.78177214 |
9 | Measles_Homo sapiens_hsa05162 | 1.74618602 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68902639 |
11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67386215 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61216806 |
13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60064525 |
14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.58762229 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50337972 |
16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50039471 |
17 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.44555098 |
18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40772930 |
19 | Malaria_Homo sapiens_hsa05144 | 1.40146508 |
20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39885032 |
21 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38085448 |
22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37650490 |
23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.35581406 |
24 | Apoptosis_Homo sapiens_hsa04210 | 1.34586914 |
25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33146904 |
26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27580019 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.25731303 |
28 | Pertussis_Homo sapiens_hsa05133 | 1.24056262 |
29 | Influenza A_Homo sapiens_hsa05164 | 1.23858626 |
30 | Tuberculosis_Homo sapiens_hsa05152 | 1.17596652 |
31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16040864 |
32 | Endometrial cancer_Homo sapiens_hsa05213 | 1.13914789 |
33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.13526034 |
34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12656713 |
35 | Insulin resistance_Homo sapiens_hsa04931 | 1.12506229 |
36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12409342 |
37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11493084 |
38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10798059 |
39 | Allograft rejection_Homo sapiens_hsa05330 | 1.09338989 |
40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05581374 |
41 | Hepatitis B_Homo sapiens_hsa05161 | 1.04324440 |
42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01749738 |
43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99906989 |
44 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99579211 |
45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99387804 |
46 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99163492 |
47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98796406 |
48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97655540 |
49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97271976 |
50 | Shigellosis_Homo sapiens_hsa05131 | 0.95874774 |
51 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.95325135 |
52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95017899 |
53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93610954 |
54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93224692 |
55 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92705363 |
56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88510688 |
57 | Adherens junction_Homo sapiens_hsa04520 | 0.88429210 |
58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88270448 |
59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88216620 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 0.88080049 |
61 | Focal adhesion_Homo sapiens_hsa04510 | 0.86867270 |
62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84678762 |
63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.84362524 |
64 | Salmonella infection_Homo sapiens_hsa05132 | 0.83484695 |
65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82387107 |
66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.82307430 |
67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82223340 |
68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80685828 |
69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80248941 |
70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.80035190 |
71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79710215 |
72 | Hepatitis C_Homo sapiens_hsa05160 | 0.79584740 |
73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.79410851 |
74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78729991 |
75 | Lysosome_Homo sapiens_hsa04142 | 0.78497350 |
76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78076157 |
77 | Platelet activation_Homo sapiens_hsa04611 | 0.77890300 |
78 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77760085 |
79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77579914 |
80 | Amoebiasis_Homo sapiens_hsa05146 | 0.77302226 |
81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77022098 |
82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76250559 |
83 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75497428 |
84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74510930 |
85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73742160 |
86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73048260 |
87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72691550 |
88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72107674 |
89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71059978 |
90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70708430 |
91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70427549 |
92 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70236444 |
93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69487454 |
94 | Glioma_Homo sapiens_hsa05214 | 0.68772040 |
95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68137177 |
96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66063647 |
97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65054742 |
98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62829997 |
99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62663404 |
100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61860748 |
101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61619487 |
102 | Prostate cancer_Homo sapiens_hsa05215 | 0.60768139 |
103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60547768 |
104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59020955 |
105 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58588989 |
106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57844577 |
107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.57480926 |
108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57079323 |
109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57020079 |
110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55524971 |
111 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55391678 |
112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54892960 |
113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54819069 |
114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53262443 |
115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52387812 |
116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51445562 |
117 | Bile secretion_Homo sapiens_hsa04976 | 0.51010613 |
118 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50606755 |
119 | Asthma_Homo sapiens_hsa05310 | 0.50597954 |
120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50022738 |
121 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49753379 |
122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49030978 |
123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48679079 |
124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48086781 |
125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46482496 |
126 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45303238 |
127 | ABC transporters_Homo sapiens_hsa02010 | 0.43606795 |
128 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43412721 |
129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43112576 |
130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42838550 |
131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41916815 |
132 | Bladder cancer_Homo sapiens_hsa05219 | 0.41834791 |
133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41096479 |
134 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40846386 |
135 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39850221 |
136 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39348597 |